# Role of Salbutamol in the Management of Transient Tachypnea of the New Born

> **NCT06921291** · PHASE1 · COMPLETED · sponsor: **Khyber Teaching Hospital** · enrollment: 60 (actual)

## Conditions studied

- TTN

## Interventions

- **DRUG:** Salbutamol (Ventolin®)

## Key facts

- **NCT ID:** NCT06921291
- **Lead sponsor:** Khyber Teaching Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06921291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06921291, "Role of Salbutamol in the Management of Transient Tachypnea of the New Born". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06921291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*